These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9219735)

  • 21. Sequential immunogene therapy with interleukin-12- and interleukin-15-engineered neuroblastoma cells cures metastatic disease in syngeneic mice.
    Croce M; Meazza R; Orengo AM; Radić L; De Giovanni B; Gambini C; Carlini B; Pistoia V; Mortara L; Accolla RS; Corrias MV; Ferrini S
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):735-42. PubMed ID: 15701863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
    Kamran MZ; Gude RP
    Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblasts.
    Windmeier C; Gressner AM
    Biochem Pharmacol; 1996 Mar; 51(5):577-84. PubMed ID: 8615892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy.
    Tsujino A; Nakamura T; Nishiura Y; Shirabe S; Furuya T; Goto H; Kawakami A; Eguchi K; Nagataki S
    J Neuroimmunol; 1997 Mar; 73(1-2):191-6. PubMed ID: 9058776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pentoxifylline reduces in vitro renal myofibroblast proliferation and collagen secretion.
    Hewitson TD; Martic M; Kelynack KJ; Pedagogos E; Becker GJ
    Am J Nephrol; 2000; 20(1):82-8. PubMed ID: 10644875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of lung homing of B16F10 by pentoxifylline, a microfilament depolymerizing agent.
    Gude RP; Ingle AD; Rao SG
    Cancer Lett; 1996 Sep; 106(2):171-6. PubMed ID: 8844969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline inhibits agonist-induced vasoconstriction in vascular smooth muscle and spontaneous peristalsis in isolated ileum.
    Ruddock MW; Hirst DG
    Oncol Res; 2005; 15(2):81-6. PubMed ID: 16119005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentoxifylline inhibits neointimal formation and stimulates constrictive vascular remodeling after arterial injury.
    Hansen PR; Holm AM; Qi JH; Ledet T; Rasmussen LM; Andersen CB
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):683-9. PubMed ID: 10547084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiosensitization by pentoxifylline in human hepatoma cell line HepG2 and its mechanism].
    Wu DH; Liu L; Chen LH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):382-5. PubMed ID: 15090303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentoxifylline augments but does not antagonize TNF alpha-mediated neuroblastoma cell differentiation: modulation of calcium mobilization but not cAMP.
    Yang KD; Chuen HL; Shaio MF
    Biochem Biophys Res Commun; 1995 Jun; 211(3):1006-14. PubMed ID: 7598686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pentoxifylline on the different steps during adhesion and transendothelial migration of flowing neutrophils.
    Bahra PS; Rainger GE; Wautier JL; Nash GB
    Cell Biochem Funct; 2001 Dec; 19(4):249-57. PubMed ID: 11746205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentoxifylline inhibits T-cell adherence to keratinocytes.
    Bruynzeel I; van der Raaij LM; Stoof TJ; Willemze R
    J Invest Dermatol; 1995 Jun; 104(6):1004-7. PubMed ID: 7539468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor alpha levels and inhibiting adhesion of T lymphocytes to extracellular matrix.
    Shirin H; Bruck R; Aeed H; Frenkel D; Kenet G; Zaidel L; Avni Y; Halpern Z; Hershkoviz R
    J Hepatol; 1998 Jul; 29(1):60-7. PubMed ID: 9696493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18.
    Samardzic T; Jankovic V; Stosic-Grujicic S; Popadic D; Trajkovic V
    Clin Exp Immunol; 2001 May; 124(2):274-81. PubMed ID: 11422205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock.
    Barroso-Aranda J; Schmid-Schönbein GW
    Biorheology; 1990; 27(3-4):401-18. PubMed ID: 2261506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline.
    Song CW; Hasegawa T; Kwon HC; Lyons JC; Levitt SH
    Radiat Res; 1992 May; 130(2):205-10. PubMed ID: 1574576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatoprotective effects of early pentoxifylline administration on hepatic injury induced by concanavalin A in rat.
    Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; AbdEl-Samad AA; El-Kharashi OA
    Can J Physiol Pharmacol; 2014 Jun; 92(6):490-7. PubMed ID: 24886185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis.
    de Campos T; Deree J; Martins JO; Loomis WH; Shenvi E; Putnam JG; Coimbra R
    Pancreas; 2008 Jul; 37(1):42-9. PubMed ID: 18580443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of pentoxifylline on the expression of hepatic TGF-beta 1, type I and type III collagen in mice with liver fibrosis due to Schistosoma japonicum infection].
    Xiong LJ; Luo DD; Zeng LL; Li SL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):209-11. PubMed ID: 12568020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophils.
    Schratzberger P; Dunzendorfer S; Reinisch N; Buratti T; Kähler CM; Tilg H; Herold M; Wiedermann CJ
    Immunopharmacology; 1999 Jan; 41(1):65-75. PubMed ID: 9950270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.